A Glycolytic Metabolite, Inflammation, and the Hidden Mechanics of Aging

A new study published in Nature Aging adds another intriguing piece to the puzzle of aging biology. Researchers led by Song and colleagues reported that phosphoenolpyruvate (PEP)—a metabolite produced near the end of glycolysis—acts as a natural brake on inflammation.

The study shows that PEP can directly inhibit the cGAS enzyme, thereby restraining activation of the cGAS–STING pathway, one of the central drivers of innate immune inflammation. When PEP levels are high, inflammatory signaling is suppressed. When PEP declines with aging, inflammatory pathways become more active.

Even more interesting, the researchers observed a biphasic pattern of PEP across aging:

• Early aging → PEP rises

• Later aging → PEP declines

Higher PEP levels in older humans were associated with lower inflammation and healthier physiological traits. In mouse models, boosting PEP before its decline reduced inflammation and improved aging-related outcomes.

These findings suggest that a simple metabolic intermediate may act as an immune checkpoint metabolite, linking metabolism directly to immune regulation.

Metabolism Is Not Just Fuel — It Is a Signaling System

For decades, metabolism was often viewed primarily as a fuel supply system—a way to generate ATP. But modern biology increasingly shows that metabolic intermediates also act as regulators of cellular signaling, immunity, and stress responses.

PEP appears to be one such metabolite.

Situated near the end of glycolysis, PEP is produced just before pyruvate enters mitochondrial oxidation. This strategic position places it at a critical interface between cytosolic metabolism and mitochondrial energy production.

Its newly discovered ability to suppress inflammatory signaling highlights a broader principle:

Metabolism itself helps regulate inflammation and aging.

A Deeper Question: Why Does PEP Rise and Then Fall With Aging?

The new study documents this biphasic pattern but leaves open a deeper question: what drives this metabolic trajectory?

One possible explanation comes from a systems-level view of metabolism and aging—what I describe as ERM mitochondrial mechanics.

The ERM Perspective: Aging as a Problem of Bioenergetic Throughput

In the ERM framework (Exposure-Related Malnutrition), aging and chronic disease are not simply caused by isolated molecular damage. Instead, many pathological processes emerge when mitochondrial energy throughput becomes constrained.

Mitochondria act as the central energy processing system of the cell. When their capacity to oxidize substrates becomes limited—because of chronic stress, environmental exposures, inflammation, or accumulated damage—cells must adapt.

The earliest adaptation is often increased reliance on glycolysis.

Phase 1: Glycolytic Compensation

When mitochondrial oxidative capacity tightens, cells increase glycolysis to maintain energy balance.

This produces several beneficial effects:

• rapid ATP generation in the cytosol

• regeneration of NAD⁺ to sustain metabolism

• accumulation of glycolytic intermediates such as PEP

These metabolites may also exert protective signaling functions.

The Nature Aging study suggests that PEP accumulation during this stage may restrain innate immune activation, preventing premature inflammation despite rising cellular stress.

In this view, early metabolic changes are adaptive responses designed to maintain stability.

Phase 2: Loss of Compensation

Over time, however, metabolic buffering systems can become exhausted.

When mitochondrial constraints worsen, glycolytic capacity may decline. As glycolysis weakens, levels of protective intermediates such as PEP may fall.

At this point, inflammatory pathways previously kept in check can become activated.

One important pathway is the cGAS–STING DNA sensing system, which detects misplaced DNA in the cytosol. Increasing evidence suggests that mitochondrial stress can lead to release of mitochondrial DNA, which can trigger this inflammatory cascade.

When metabolic brakes such as PEP disappear, this pathway may become chronically activated, contributing to what we now call inflammaging.

Multiple Routes From Mitochondrial Stress to Inflammation

The cGAS–STING pathway is only one of several routes linking mitochondrial dysfunction to inflammation.

Mitochondrial stress can also activate the Integrated Stress Response, a cellular program that coordinates adaptation to metabolic strain.

Under sustained stress, this response can interact with innate immune systems such as the NLRP3 inflammasome, which drives the release of inflammatory cytokines like IL-1β.

Thus, mitochondrial dysfunction can generate inflammatory signals through multiple overlapping pathways, including:

• DNA sensing (cGAS–STING)

• inflammasome activation

• stress signaling networks

• redox imbalance.

A Single Upstream Constraint, Many Aging Hallmarks

This systems view helps explain why aging appears to involve many seemingly unrelated biological hallmarks.

The same upstream constraint—declining mitochondrial throughput—can generate multiple downstream effects:

• chronic inflammation

• cellular senescence

• metabolic inflexibility

• impaired tissue repair

• neurodegeneration

• immune dysregulation.

Rather than independent problems, these processes may represent different expressions of the same underlying bioenergetic stress.

Metabolic Adaptation Before Metabolic Collapse

The PEP findings highlight an important insight: aging may involve a sequence of adaptation followed by exhaustion.

Early metabolic changes may actually protect the organism, buffering inflammation and maintaining energy balance.

Only when these adaptive mechanisms fail do we see the full emergence of aging phenotypes.

Understanding these transitions—between compensation and collapse—may be one of the most important challenges in aging biology.

A New Direction for Aging Research

The discovery that a simple glycolytic metabolite can regulate immune signaling illustrates how tightly metabolism and immunity are intertwined.

But it also raises a broader possibility.

Instead of targeting individual downstream pathways—one cytokine, one receptor, one signaling molecule—future interventions may need to focus on restoring metabolic throughput and resilience.

If the upstream energy system remains constrained, suppressing one pathway may simply push pathology into another.

By contrast, restoring the cell’s capacity to process energy and maintain redox balance may stabilize multiple systems simultaneously.

Aging as a Systems Problem

The emerging picture suggests that aging is not driven by a single cause. It is the cumulative result of network-level stress within the cell’s energy infrastructure.

Studies like the one from Nature Aging help illuminate specific molecular details—such as the role of PEP in regulating inflammation. But they also reinforce a deeper principle:

Metabolism is the central language through which cells coordinate stress, immunity, and survival.

Understanding that language may ultimately help us slow, prevent, or even reverse aspects of biological aging.

Reference

Song, Z., Hu, H., Zhang, W., Zheng, X., Liang, L., Zhao, B., et al. (2026). The glycolytic metabolite phosphoenolpyruvate restricts cGAS-driven inflammation to promote healthy aging. Nature Aging. https://doi.org/10.1038/s43587-026-01087-1